Utilization of direct smears of thyroid fine-needle aspirates for ancillary molecular testing: A comparison of two proprietary testing platforms.
Kristen L PartykaMelissa L RandolphKaren A LawrenceHarvey CramerHoward H WuPublished in: Diagnostic cytopathology (2018)
This study demonstrates that two molecular testing platforms performed equally well using our stained direct smears. Both molecular tests revealed a 100% negative predictive rate. RosettaGX showed a 75% positive predictive value in comparison to 60% for ThyGenX/ThyraMIR.
Keyphrases